CMS Open Payments · Program Year 2024
Ares Trading SA
Ares Trading SA reported $1,884,332.37 across General Payments, Research, and Ownership to 59 physicians and teaching hospitals across 1,047 transactions.
- $1.9M Top quartile payer
- All-tracks total
- 1,047 Above-median volume
- Transactions
- 59 Below-median reach
- Recipients
- +$127.8K
- General Payments vs PY2023
Ares Trading SA reported $1,884,332.37 across all CMS Open Payments tracks (General + Research + Ownership) to 59 physicians and teaching hospitals in Program Year 2024 - ranking #466 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $254,285.83, averaging $31.9K per recipient.
How Ares Trading SA's $1.9M all-tracks total breaks down
Ares Trading SA's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
26/100
Total payments
F
27/100
Transaction volume
F
18/100
Physician reach
F
10/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer ares-trading-sa Ares Trading SA
$1.9M · #466/1,925 · 0.0% industry · PY2024
- TOT $1.9M
- RANK #466
- SHARE 0.0%
- TXN 1,047
- RCP 59
- CAT 4
- GEN $254.3K
- ΔGEN +$127.8K
- TOP1 16.0%
- PY 2024
Volume peers
Nearest volume peer: Bayer Healthcare LLC ($1.9M)
Ares Trading SA sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Ares Trading SA's CMS-reported General Payments increased by $127.8K (+101.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: ARES TRADING SAPY2024: Ares Trading SA. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $126,487.16
- PY2024
- $254,285.83
What the Data Shows for Ares Trading SA
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Ares Trading SA, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Services Other Than Consulting" at $156.4K, accounting for 61.5% of this company's General Payments and 13 transactions.
General Payment Breakdown by Type
Across 4 types of general payments, Ares Trading SA's largest category was "Compensation for Services Other Than Consulting" at $156.4K - 61.5% of General Payments.
Ares Trading SA reports 4 general-payment categories - the top three are Compensation for Services Other Than Consulting (61.5%), Consulting Fee (27.5%), and Travel and Lodging (10.5%). The remaining 1 category make up 0.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Ares Trading SA divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $156.4K | 13 | 61.5% |
| Consulting Fee | $69.8K | 15 | 27.5% |
| Travel and Lodging | $26.6K | 17 | 10.5% |
| Food and Beverage | $1.4K | 14 | 0.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $143,683.85 (56.5%) of $254,285.83 in this company's General Payments records across 21 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Ares Trading SA
The five named recipients with the highest reported General Payments from this company
- 1
Christopher C Laganke
$40,623.57 across 5 reported transactions
- 2
Gabriel Pardo
$33,596.69 across 5 reported transactions
- 3
Donald Negroski
$23,758.37 across 8 reported transactions
- 4
George Katsamakis
$23,173.92 across 5 reported transactions
- 5
Bruce L Hughes
$22,531.30 across 8 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Ares Trading SA ranks #466 of 1,925 by total payments (top 24% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,067 of 1,838 by HHI (bottom 42% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Ortho Development Corporation : $3.6M total payments, HHI 918
- EDW Pharma, Inc. : $2.6K total payments, HHI 916
- Onkos Surgical, Inc. : $402.3K total payments, HHI 915
- Kinex Medical Company LLC : $133.04 total payments, HHI 915
- Choice Spine, LLC : $1.0M total payments, HHI 912
- SOMAVAC Medical Solutions, Inc. : $2.8K total payments, HHI 906
- Ares Trading SA (this company) : $254.3K total payments, HHI 902
- SprintRay Inc : $106.8K total payments, HHI 897
- Siemens Medical Solutions USA, Inc. : $13.3M total payments, HHI 895
- Hyhte Holdings Inc. : $1.3M total payments, HHI 892
- Nuo Therapeutics : $833.09 total payments, HHI 891
- Motiva USA, LLC : $482.1K total payments, HHI 886
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Ares Trading SA's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Ares Trading SA.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Ares Trading SA.
Showing 6 of 1,924 companies with CMS-reported payment data.
QOL Medical, LLC
iRhythm Technologies, Inc.
Pharming Healthcare, Inc.
Lantheus Medical Imaging, Inc.
Milestone Scientific Inc.
Put this to use
Ares Trading SA ranks #466 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Ares Trading SA sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Ares Trading SA. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.